ALK and cancer: Other partners encoding KIF5B-ALK (<1%), TFG-ALK (2%), KLC1-ALK (<5%), PTPN3-ALK (<1%) and in rare events and isolated cases the aberrant proteins HIP1-ALK, TPR-ALK, STRN-ALK, and A2M-ALK have also been described in cancers [4–6].